NanoViricides's market cap is currently $22.68M. The company's EPS TTM is $-0.717; its P/E ratio is ―; NanoViricides is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -759.01K	$ -747.53K	$ -723.33K	$ -704.54K	$ -699.72K
Operating Income	$ -8.52M	$ -8.94M	$ -8.11M	$ -8.74M	$ -8.00M
EBITDA	$ -7.76M	$ -7.84M	$ -7.38M	$ -8.03M	$ -7.30M
Net Income	$ -8.29M	$ -8.59M	$ -8.10M	$ -8.91M	$ -13.40M
Balance Sheet
Cash & Short-Term Investments	$ 4.80M	$ 8.15M	$ 14.07M	$ 20.52M	$ 13.71M
Total Assets	$ 12.82M	$ 16.90M	$ 23.49M	$ 30.26M	$ 23.91M
Total Debt	$ 0.00	$ 0.00	$ 94.79K	$ 95.31K	$ 1.14M
Net Debt	$ -4.80M	$ -8.15M	$ -13.97M	$ -20.42M	$ -12.56M
Total Liabilities	$ 1.36M	$ 2.03M	$ 412.84K	$ 351.15K	$ 2.16M
Stockholders' Equity	$ 11.46M	$ 14.87M	$ 23.08M	$ 29.91M	$ 21.76M
Cash Flow
Free Cash Flow	$ -6.47M	$ -5.82M	$ -6.22M	$ -8.45M	$ -6.67M
Operating Cash Flow	$ -6.32M	$ -5.67M	$ -5.89M	$ -8.21M	$ -6.67M
Investing Cash Flow	$ -156.56K	$ -151.71K	$ -324.35K	$ -238.76K	$ -8.64K
Financing Cash Flow	$ 3.12M	$ -94.79K	$ -234.72K	$ 15.26M	$ 17.83M

Currency in USD

NanoViricides Earnings and Revenue History

Income Statement >

NanoViricides Debt to Assets

Balance Sheet >

NanoViricides Cash Flow

Cash Flow >

NanoViricides Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing